Get startedLog in
    Picture of ExpreS2ion Biotech Holding AB logo

    EXPRS2 — ExpreS2ion Biotech Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Expres2ion Biotech Q2 Profit For Period Down At Sek 2.5 Mln

    Picture of ExpreS2ion Biotech Holding AB logoExpreS2ion Biotech Holding AB
    15/08/2024 07:49
    Aug 15 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * Q2 PROFIT FOR PERIOD OF SEK 2.5 MILLION VERSUS LOSS OF SEK
30
MILLION YEAR AGO
    * WITH CASH POSITION OF SEK 68.6 MILLION AT END OF Q2,
EXPRES2ION
IS FUNDED TO INITIATE ES2B-C001 FIRST-IN-HUMAN PHASE I TRIAL
    * EXCITED TO ADVANCE ES2B-C001 INTO CLINICAL DEVELOPMENT AND
LEVERAGE OUR TECHNOLOGY PLATFORM IN OUR COLLABORATIVE PROJECTS
    * Q2 OPERATING INCOME AT SEK 2.4 MILLION VERSUS SEK 2.1
MILLION

Source text for Eikon:  ID:nWkrYHzzt 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))

    Recent news on ExpreS2ion Biotech Holding AB

    See all news